1. Article › Research › Peer-reviewed
2. Published

   Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial.

   Russell, I. T., Slegg, G. P., Roberts, S. H., Bedson, E., Hughes, D., Lloyd, K., Moat, S., Pirmohamed, M., Slegg, G., Tranter, R., Whitaker, R., Wilkinson, C. & Russell, I., 15 Nov 2007, In: BMC Psychiatry. 7, 1, p. 65

   Research output: Contribution to journal › Article › peer-review

3. Published

   Folate Augmentation of Treatment-Evaluation for Depression (FolATED): randomised trial and economic evaluation

   Bedson, E., Bell, D., Carr, D., Carter, B., Hughes, D., Jorgensen, A., Lewis, H., Lloyd, K., McCaddon, A., Moat, S., Pink, J., Pirmohamed, M., Roberts, S., Russell, I., Sylvestre, Y., Tranter, R., Whitaker, R., Wilkinson, C. & Williams, N., Jul 2014, In: Health Technology Assessment. 18, 48, p. 1-159

   Research output: Contribution to journal › Article › peer-review

4. Published

   Follow-up of cancer in primary care versus secondary care: systematic review

   Lewis, R. A., Neal, R. D., Williams, N. H., France, B., Hendry, M., Russell, D., Hughes, D. A., Russell, I., Stuart, N. S. A., Weller, D. & Wilkinson, C., 1 Jul 2009, In: British Journal of General Practice. 59, 564, p. e234-e247

   Research output: Contribution to journal › Article › peer-review

5. Published

   From NCE to NICE: the role of pharmacoeconomics

   Hughes, D. & Hughes, D. A., 1 Sept 2010, In: British Journal of Clinical Pharmacology. 70, 3, p. 317-319

   Research output: Contribution to journal › Article › peer-review

6. Published

   Generalisability and Cost-Impact of Antibiotic-Impregnated Central Venous Catheters for Reducing Risk of Bloodstream Infection in Paediatric Intensive Care Units in England

   Harron, K., Mok, Q., Hughes, D., Muller-Pebody, B., Parslow, R., Ramnarayan, P. & Gilbert, R., 21 Mar 2016, In: PLoS ONE. 11, 3, p. e0151348

   Research output: Contribution to journal › Article › peer-review

7. Published

   Generic and therapeutic substitutions in the UK: are they a good thing?

   Hughes, D., Duerden, M. G. & Hughes, D. A., 1 Sept 2010, In: British Journal of Clinical Pharmacology. 70, 3, p. 335-341

   Research output: Contribution to journal › Article › peer-review

8. Published

   Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study.

   Hughes, D., Jorgensen, A. L., Al-Zubiedi, S., Zhang, J. E., Keniry, A., Hanson, A., Hughes, D. A., Van Eker, D., Stevens, L., Hawkins, K., Toh, C. H., Kamali, F., Daly, A. K., Fitzmaurice, D., Coffey, A., Williamson, P. R., Park, B. K., Deloukas, P. & Pirmohamed, M., 1 Oct 2009, In: Pharmacogenetics and Genomics. 19, 10, p. 800-812

   Research output: Contribution to journal › Article › peer-review

9. Published

   HLA-B*5701 and abacavir hypersensitivity - Reply.

   Hughes, D., Hughes, D. A., Park, B. K. & Pirmohamed, M., 1 Nov 2004, In: Pharmacogenetics. 14, 11, p. 784

   Research output: Contribution to journal › Article › peer-review

10. Published

    HTAs and rare diseases: How to assess their cost-effectiveness

    Hughes, D., Phillips, C. J. & Hughes, D. A., 1 Nov 2011, In: Pharmaceuticals Policy and Law. 13, 3-4, p. 161-165

    Research output: Contribution to journal › Article › peer-review

11. Published

    Health utilities and costs for Motor Neurone Disease

    Moore, A., Young, C. A. & Hughes, D., Nov 2019, In: Value in Health. 22, 11, p. 1257-1265

    Research output: Contribution to journal › Article › peer-review